RCUS News - Candlesense

Arcus Biosciences to Participate in Three Upcoming Investor Conferences

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for pati...

Investor events

9 days ago

Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies fo...

Are there any macro‑economic or sector‑specific factors that could amplify or mitigate the reaction to this earnings and pipeline update? What is the potential impact of the earnings release on the stock's short‑term volatility and trading volume? How might the updated data from 125 patients influence market perception of the company's lead candidates and potential market share?

Earnings

23 days ago

Arcus Biosciences Announces New Employment Inducement Grants

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies fo...

Employment

3 months ago